Last Close
Apr 06  •  04:00PM ET
10.59
Dollar change
+0.03
Percentage change
0.28
%
Index- P/E35.72 EPS (ttm)0.30 Insider Own19.52% Shs Outstand19.78M Perf Week0.09%
Market Cap260.33M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.78M Perf Month-0.75%
Enterprise Value258.91M PEG- EPS next Q- Inst Own74.52% Short Float0.25% Perf Quarter-0.24%
Income7.29M P/S- EPS this Y- Inst Trans- Short Ratio1.09 Perf Half Y0.47%
Sales0.00M P/B1.34 EPS next Y- ROA3.66% Short Interest0.05M Perf YTD0.09%
Book/sh7.92 P/C182.05 EPS next 5Y- ROE3.81% 52W High10.74 -1.36% Perf Year4.13%
Cash/sh0.06 P/FCF- EPS past 3/5Y- - ROIC3.74% 52W Low10.04 5.48% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility0.39% 0.44% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.19 Sales Y/Y TTM- Profit Margin- RSI (14)45.36 Recom-
Dividend Gr. 3/5Y- - Current Ratio1.19 EPS Q/Q29.77% SMA20-0.52% Beta-0.02 Target Price-
Payout0.00% Debt/Eq0.00 Sales Q/Q- SMA50-0.44% Rel Volume0.00 Prev Close10.56
Employees3 LT Debt/Eq0.00 Earnings- SMA2000.70% Avg Volume45.87K Price10.59
IPODec 16, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume150 Change0.28%
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.